Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 4Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4Carcinoma, Hepatocellular 3Solid Tumor 2Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Turcot syndrome 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Cancer Resectable 1Pancreatic Cancer Metastatic 1Neoplasms 1Multiple Primary Lung Cancer 1Metastatic Gastroesophageal Junction Adenocarcinoma 1Melanoma 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Cervical Carcinoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Advanced Solid Tumours 1Advanced Solid Tumor 1Advanced Intrahepatic Cholangiocarcinoma 1Advanced Biliary Tract Cancer 1Adenocarcinoma 1

Interventions

Cetuximab 44Oxaliplatin 39Irinotecan 38Fluorouracil 36Capecitabine 36pembrolizumab 35Leucovorin 35Bevacizumab 35Nivolumab 21Gemcitabine 17regorafenib 13Panitumumab 12IFL protocol 12Folfox protocol 12Cyclophosphamide 12Pemetrexed 11Cisplatin 11tislelizumab 9Paclitaxel 9HMPL-013 9Carboplatin 9130-nm albumin-bound paclitaxel 8durvalumab 7Specimen Handling 7Docetaxel 7trametinib 6Trifluridine 6Ipilimumab 6Drug Therapy 6trifluridine tipiracil drug combination 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Colorectal Neoplasms × sintilimab × Clear all
NCT06195670 2024-01-08

Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC

Zhejiang Cancer Hospital

Phase 1/2 Not yet recruiting
220 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡